Glenmark Pharmaceuticals Ltd (GREY:GLKQY)
$ 0 0 (0%) Market Cap: - Enterprise Value: 2.62 Bil PE Ratio: 0 PB Ratio: 5.18 GF Score: 74/100

Q4 2024 Glenmark Pharmaceuticals Ltd Earnings Call Transcript

May 27, 2024 / 03:00AM GMT
Operator

Good morning, ladies and gentlemen. Welcome to the Q4 FY24 earnings conference call of Glenmark Pharmaceuticals Limited. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Utkarsh Gandhi, General Manager, Investor Relations, for Glenmark Pharmaceuticals. Thank you, and over to you, sir.

Utkarsh Gandhi
Glenmark Pharmaceuticals Ltd - General Manager, Investor Relations

Thank you, Lizanne. Good morning, everyone. Welcome to the Q4 FY24 results conference call of Glenmark Pharmaceuticals Limited. Before we start the Q&A, we'll review the overall performance of the company for the fourth quarter and the full-year 2024.

For the fourth quarter of FY24, Glenmark's consolidated revenue from operations was at INR30,630 million as against INR30,005 million in the corresponding quarter last year, recording an overall year-on-year growth of 2.1%. For the 12 months of FY24, Glenmark's consolidated revenue was at INR118,131 million as against INR115,832 million, recording a YoY growth of 2%

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot